StockNews.AI
TNDM
StockNews.AI
138 days

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

1. Tandem Diabetes plans Q1 2025 results release on April 30, 2025. 2. The company will hold a conference call to discuss financial results.

Earnings
-4.42%Current Return
VS
-6.03%S&P 500
$17.6604/03 04:22 PM EDTEvent Start
$16.8804/04 10:30 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

The scheduled earnings report typically reflects current operational status, yet may not indicate significant changes.

How important is it?

Earnings reports usually influence stock price; however, no prior estimates or projections suggest high volatility.

Why Short Term?

Investor reactions may primarily occur immediately after the earnings release, but long-term implications depend on performance metrics.

Related Companies

DXCMBAYRYPODD
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial markets close on Wednesday, April 30, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Diabe.

Related News